Sleep disorders result in a lack of deep and restorative sleep.
The sleep disorder therapeutics market is expected to witness a high growth over the forecast period owing to the increasing prevalence of sleep disorder in modern times.
Market Analysis and Insights: Global Sleep Disorder Therapeutics Market
The global Sleep Disorder Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Sleep Disorder Therapeutics Scope and Market Size
Sleep Disorder Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sleep Disorder Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Sanofi
Sunovion Pharmaceuticals
Takeda Pharmaceutical
Somaxon Pharmaceuticals
Vanda Pharmaceuticals
Eli Lilly
GSK
Neurim Pharmaceuticals
Sleep Disorder Therapeutics Breakdown Data by Type
Insomnia
Excessive Sleep
Disturbed Sleep
Sleep Disorder Therapeutics Breakdown Data by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
The sleep disorder therapeutics market is expected to witness a high growth over the forecast period owing to the increasing prevalence of sleep disorder in modern times.
Market Analysis and Insights: Global Sleep Disorder Therapeutics Market
The global Sleep Disorder Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Sleep Disorder Therapeutics Scope and Market Size
Sleep Disorder Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sleep Disorder Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Sanofi
Sunovion Pharmaceuticals
Takeda Pharmaceutical
Somaxon Pharmaceuticals
Vanda Pharmaceuticals
Eli Lilly
GSK
Neurim Pharmaceuticals
Sleep Disorder Therapeutics Breakdown Data by Type
Insomnia
Excessive Sleep
Disturbed Sleep
Sleep Disorder Therapeutics Breakdown Data by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sleep Disorder Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Sleep Disorder Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Insomnia
1.4.3 Excessive Sleep
1.4.4 Disturbed Sleep
1.5 Market by Application
1.5.1 Global Sleep Disorder Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Sleep Disorder Therapeutics Market Perspective (2015-2026)
2.2 Global Sleep Disorder Therapeutics Growth Trends by Regions
2.2.1 Sleep Disorder Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Sleep Disorder Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Sleep Disorder Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Sleep Disorder Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Sleep Disorder Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Sleep Disorder Therapeutics Players by Market Size
3.1.1 Global Top Sleep Disorder Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Sleep Disorder Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Sleep Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Sleep Disorder Therapeutics Market Concentration Ratio
3.2.1 Global Sleep Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Sleep Disorder Therapeutics Revenue in 2019
3.3 Sleep Disorder Therapeutics Key Players Head office and Area Served
3.4 Key Players Sleep Disorder Therapeutics Product Solution and Service
3.5 Date of Enter into Sleep Disorder Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Sleep Disorder Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Sleep Disorder Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Sleep Disorder Therapeutics Market Size by Application (2015-2020)
5.2 Global Sleep Disorder Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Sleep Disorder Therapeutics Market Size (2015-2020)
6.2 Sleep Disorder Therapeutics Key Players in North America (2019-2020)
6.3 North America Sleep Disorder Therapeutics Market Size by Type (2015-2020)
6.4 North America Sleep Disorder Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Sleep Disorder Therapeutics Market Size (2015-2020)
7.2 Sleep Disorder Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Sleep Disorder Therapeutics Market Size by Type (2015-2020)
7.4 Europe Sleep Disorder Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Sleep Disorder Therapeutics Market Size (2015-2020)
8.2 Sleep Disorder Therapeutics Key Players in China (2019-2020)
8.3 China Sleep Disorder Therapeutics Market Size by Type (2015-2020)
8.4 China Sleep Disorder Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Sleep Disorder Therapeutics Market Size (2015-2020)
9.2 Sleep Disorder Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Sleep Disorder Therapeutics Market Size by Type (2015-2020)
9.4 Japan Sleep Disorder Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Sleep Disorder Therapeutics Market Size (2015-2020)
10.2 Sleep Disorder Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Sleep Disorder Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Sleep Disorder Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Sleep Disorder Therapeutics Market Size (2015-2020)
11.2 Sleep Disorder Therapeutics Key Players in India (2019-2020)
11.3 India Sleep Disorder Therapeutics Market Size by Type (2015-2020)
11.4 India Sleep Disorder Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Sleep Disorder Therapeutics Market Size (2015-2020)
12.2 Sleep Disorder Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Sleep Disorder Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Sleep Disorder Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Sleep Disorder Therapeutics Introduction
13.1.4 Sanofi Revenue in Sleep Disorder Therapeutics Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Sunovion Pharmaceuticals
13.2.1 Sunovion Pharmaceuticals Company Details
13.2.2 Sunovion Pharmaceuticals Business Overview
13.2.3 Sunovion Pharmaceuticals Sleep Disorder Therapeutics Introduction
13.2.4 Sunovion Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.2.5 Sunovion Pharmaceuticals Recent Development
13.3 Takeda Pharmaceutical
13.3.1 Takeda Pharmaceutical Company Details
13.3.2 Takeda Pharmaceutical Business Overview
13.3.3 Takeda Pharmaceutical Sleep Disorder Therapeutics Introduction
13.3.4 Takeda Pharmaceutical Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.3.5 Takeda Pharmaceutical Recent Development
13.4 Somaxon Pharmaceuticals
13.4.1 Somaxon Pharmaceuticals Company Details
13.4.2 Somaxon Pharmaceuticals Business Overview
13.4.3 Somaxon Pharmaceuticals Sleep Disorder Therapeutics Introduction
13.4.4 Somaxon Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.4.5 Somaxon Pharmaceuticals Recent Development
13.5 Vanda Pharmaceuticals
13.5.1 Vanda Pharmaceuticals Company Details
13.5.2 Vanda Pharmaceuticals Business Overview
13.5.3 Vanda Pharmaceuticals Sleep Disorder Therapeutics Introduction
13.5.4 Vanda Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.5.5 Vanda Pharmaceuticals Recent Development
13.6 Eli Lilly
13.6.1 Eli Lilly Company Details
13.6.2 Eli Lilly Business Overview
13.6.3 Eli Lilly Sleep Disorder Therapeutics Introduction
13.6.4 Eli Lilly Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.6.5 Eli Lilly Recent Development
13.7 GSK
13.7.1 GSK Company Details
13.7.2 GSK Business Overview
13.7.3 GSK Sleep Disorder Therapeutics Introduction
13.7.4 GSK Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.7.5 GSK Recent Development
13.8 Neurim Pharmaceuticals
13.8.1 Neurim Pharmaceuticals Company Details
13.8.2 Neurim Pharmaceuticals Business Overview
13.8.3 Neurim Pharmaceuticals Sleep Disorder Therapeutics Introduction
13.8.4 Neurim Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.8.5 Neurim Pharmaceuticals Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sleep Disorder Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Sleep Disorder Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Insomnia
1.4.3 Excessive Sleep
1.4.4 Disturbed Sleep
1.5 Market by Application
1.5.1 Global Sleep Disorder Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Sleep Disorder Therapeutics Market Perspective (2015-2026)
2.2 Global Sleep Disorder Therapeutics Growth Trends by Regions
2.2.1 Sleep Disorder Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Sleep Disorder Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Sleep Disorder Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Sleep Disorder Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Sleep Disorder Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Sleep Disorder Therapeutics Players by Market Size
3.1.1 Global Top Sleep Disorder Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Sleep Disorder Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Sleep Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Sleep Disorder Therapeutics Market Concentration Ratio
3.2.1 Global Sleep Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Sleep Disorder Therapeutics Revenue in 2019
3.3 Sleep Disorder Therapeutics Key Players Head office and Area Served
3.4 Key Players Sleep Disorder Therapeutics Product Solution and Service
3.5 Date of Enter into Sleep Disorder Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Sleep Disorder Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Sleep Disorder Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Sleep Disorder Therapeutics Market Size by Application (2015-2020)
5.2 Global Sleep Disorder Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Sleep Disorder Therapeutics Market Size (2015-2020)
6.2 Sleep Disorder Therapeutics Key Players in North America (2019-2020)
6.3 North America Sleep Disorder Therapeutics Market Size by Type (2015-2020)
6.4 North America Sleep Disorder Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Sleep Disorder Therapeutics Market Size (2015-2020)
7.2 Sleep Disorder Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Sleep Disorder Therapeutics Market Size by Type (2015-2020)
7.4 Europe Sleep Disorder Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Sleep Disorder Therapeutics Market Size (2015-2020)
8.2 Sleep Disorder Therapeutics Key Players in China (2019-2020)
8.3 China Sleep Disorder Therapeutics Market Size by Type (2015-2020)
8.4 China Sleep Disorder Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Sleep Disorder Therapeutics Market Size (2015-2020)
9.2 Sleep Disorder Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Sleep Disorder Therapeutics Market Size by Type (2015-2020)
9.4 Japan Sleep Disorder Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Sleep Disorder Therapeutics Market Size (2015-2020)
10.2 Sleep Disorder Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Sleep Disorder Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Sleep Disorder Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Sleep Disorder Therapeutics Market Size (2015-2020)
11.2 Sleep Disorder Therapeutics Key Players in India (2019-2020)
11.3 India Sleep Disorder Therapeutics Market Size by Type (2015-2020)
11.4 India Sleep Disorder Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Sleep Disorder Therapeutics Market Size (2015-2020)
12.2 Sleep Disorder Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Sleep Disorder Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Sleep Disorder Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Sleep Disorder Therapeutics Introduction
13.1.4 Sanofi Revenue in Sleep Disorder Therapeutics Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Sunovion Pharmaceuticals
13.2.1 Sunovion Pharmaceuticals Company Details
13.2.2 Sunovion Pharmaceuticals Business Overview
13.2.3 Sunovion Pharmaceuticals Sleep Disorder Therapeutics Introduction
13.2.4 Sunovion Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.2.5 Sunovion Pharmaceuticals Recent Development
13.3 Takeda Pharmaceutical
13.3.1 Takeda Pharmaceutical Company Details
13.3.2 Takeda Pharmaceutical Business Overview
13.3.3 Takeda Pharmaceutical Sleep Disorder Therapeutics Introduction
13.3.4 Takeda Pharmaceutical Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.3.5 Takeda Pharmaceutical Recent Development
13.4 Somaxon Pharmaceuticals
13.4.1 Somaxon Pharmaceuticals Company Details
13.4.2 Somaxon Pharmaceuticals Business Overview
13.4.3 Somaxon Pharmaceuticals Sleep Disorder Therapeutics Introduction
13.4.4 Somaxon Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.4.5 Somaxon Pharmaceuticals Recent Development
13.5 Vanda Pharmaceuticals
13.5.1 Vanda Pharmaceuticals Company Details
13.5.2 Vanda Pharmaceuticals Business Overview
13.5.3 Vanda Pharmaceuticals Sleep Disorder Therapeutics Introduction
13.5.4 Vanda Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.5.5 Vanda Pharmaceuticals Recent Development
13.6 Eli Lilly
13.6.1 Eli Lilly Company Details
13.6.2 Eli Lilly Business Overview
13.6.3 Eli Lilly Sleep Disorder Therapeutics Introduction
13.6.4 Eli Lilly Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.6.5 Eli Lilly Recent Development
13.7 GSK
13.7.1 GSK Company Details
13.7.2 GSK Business Overview
13.7.3 GSK Sleep Disorder Therapeutics Introduction
13.7.4 GSK Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.7.5 GSK Recent Development
13.8 Neurim Pharmaceuticals
13.8.1 Neurim Pharmaceuticals Company Details
13.8.2 Neurim Pharmaceuticals Business Overview
13.8.3 Neurim Pharmaceuticals Sleep Disorder Therapeutics Introduction
13.8.4 Neurim Pharmaceuticals Revenue in Sleep Disorder Therapeutics Business (2015-2020)
13.8.5 Neurim Pharmaceuticals Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
